XML 70 R52.htm IDEA: XBRL DOCUMENT v3.25.0.1
Note 21 - Mercantile Bank Corporation (Parent Company Only) Condensed Financial Statements (Tables)
12 Months Ended
Dec. 31, 2024
Notes Tables  
Condensed Balance Sheet [Table Text Block]

(Dollars in thousands)

 2024  2023 

ASSETS

        

Cash and cash equivalents

 $17,420  $18,969 

Investments in subsidiaries

  691,563   629,710 

Other assets

  18,188   15,122 
         

Total assets

 $727,171  $663,801 
         

LIABILITIES AND SHAREHOLDERS’ EQUITY

        

Liabilities

 $3,001  $3,040 

Subordinated debentures

  50,330   49,644 

Subordinated notes

  89,314   88,971 

Shareholders’ equity

  584,526   522,146 
         

Total liabilities and shareholders’ equity

 $727,171  $663,801 
Condensed Income Statement [Table Text Block]

(Dollars in thousands)

 2024  2023  2022 

Income

            

Interest and dividends from subsidiaries

 $30,061  $26,660  $26,056 

Total income

  30,061   26,660   26,056 
             

Expenses

            

Interest expense

  8,203   8,091   6,104 

Other operating expenses

  5,647   5,674   5,645 

Total expenses

  13,850   13,765   11,749 
             

Income before income tax benefit and equity in undistributed net income of subsidiary

  16,211   12,895   14,307 
             

Federal income tax benefit

  (3,240)  (2,858)  (2,535)
             

Equity in undistributed net income of subsidiary

  60,142   66,464   44,221 
             

Net income

 $79,593  $82,217  $61,063 
             

Other comprehensive income (loss)

  662   14,854   (61,612)

Comprehensive income (loss)

 $80,255  $97,071  $(549)
Condensed Cash Flow Statement [Table Text Block]

(Dollars in thousands)

 2024 2023  2022 

Cash flows from operating activities

            

Net income

 $79,593  $82,217  $61,063 

Adjustments to reconcile net income to net cash from operating activities:

            

Equity in undistributed net income of subsidiary

  (60,142)  (66,464)  (44,221)

Stock-based compensation expense

  3,316   3,384   3,377 

Stock grants to directors for retainer fees

  423   350   359 

Change in other assets

  (4,116)  (128)  858 

Change in other liabilities

  990   1,045   1,636 

Net cash from operating activities

  20,064   20,404   23,072 
             

Cash flows from investing activities

            

Net capital investment into subsidiaries

  0   0   (15,000)

Net cash for investing activities

  0   0   (15,000)
             

Cash flows from financing activities

            

Stock option exercises, net of cashless exercises

  0   0   36 

Employee stock purchase plan

  50   45   45 

Dividend reinvestment plan

  810   891   867 

Net proceeds from subordinated notes issuance

  0   0   14,645 

Cash dividends on common stock

  (22,473)  (21,004)  (19,602)

Net cash for financing activities

  (21,613)  (20,068)  (4,009)
             

Net change in cash and cash equivalents

  (1,549)  336   4,063 
             

Cash and cash equivalents at beginning of period

  18,969   18,633   14,570 
             

Cash and cash equivalents at end of period

 $17,420  $18,969  $18,633